✦ LIBER ✦

S42 Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients – design and baseline data ‘LIBERATE’ trial

✍ Scribed by E. Kubista; P. Kenemans; J. Foidart; C. Yip; B. von Schoultz; P. Sismondi; R. Vassilopoulou-Sellin; M. Beckmann; N. Bundred

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of tibolone in the treatment of v

✍ E. Kubista; P. Kenemans; J.M. Foidart; C.H. Yip; B. von Schoultz; P. Sismondi; R 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Treatment of vasomotor symptoms with tib

✍ N. Bundred; Foidart; P. Kenemans; E. Kubista; B. von Schoultz; P. Sismondi; R. V 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Erratum to “Safety of tibolone in the tr

✍ P. Kenemans; E. Kubista; J.M. Foidart; C.H. Yip; B. von Schoultz; P. Sismondi; R 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Effects of tibolone on climacteric sympt

✍ Piero Sismondi; Rainer Kimmig; Ernst Kubista; Nicoletta Biglia; Jan Egberts; Roe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Safety and efficacy of tibolone in breas

✍ Peter Kenemans; Nigel J Bundred; Jean-Michel Foidart; Ernst Kubista; Bo von Scho 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 272 KB

PIH16 COST-EFFECTIVENESS OF DESVENLAFAXI

✍ M.A. Ramírez-Ramírez; G. Peniche-Otero; J.F. Mould-Quevedo; C. Nuño-Langre; E. M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB